Technical Analysis on vaccine

Screening Filters

1. Market Cap ≥ $2,000,000,000

   • Purpose: Focus on larger, more established vaccine/biotech companies.
   • Rationale:
     • In vaccine development, meaningful players are often mid- to large-cap biopharma/biotech firms or diversified healthcare companies with vaccine divisions.
     • Larger caps tend to have better disclosure, more analyst coverage, and deeper pipelines, which makes technical patterns more reliable (less prone to wild, low-float swings seen in tiny biotech names).

2. Monthly Average Dollar Volume ≥ $1,000,000

   • Purpose: Ensure stocks are sufficiently liquid for technical analysis and practical trading.
   • Rationale:
     • Technical indicators (RSI, moving averages, chart patterns) work better on actively traded names where price reflects broad market participation.
     • Adequate dollar volume reduces slippage and the impact of single trades, giving more trustworthy signals and making entries/exits more feasible in real life.

3. RSI Category: “Moderate”

   • Purpose: Avoid stocks that are extremely overbought or oversold, and instead capture names in a more “tradable” middle zone.
   • Rationale:
     • For technical analysis, a “moderate” RSI (typically neither below ~30 nor above ~70) suggests price is not at an extreme.
     • This is useful when the goal is to study chart structure, trend continuation, support/resistance, or potential setups without the distortion of capitulation or blow-off moves.
     • For vaccine/biotech specifically, avoiding very stretched RSI can help sidestep hype-driven spikes around trial/news events where risk is highest.

4. PriceAboveMA20 (Price above 20-day moving average)

   • Purpose: Focus on stocks that are in a short-term uptrend or at least showing near-term technical strength.
   • Rationale:
     • The 20-day moving average is a commonly used short-term trend gauge. Price above this line often indicates positive momentum and buyer control over the recent period.
     • For “technical analysis on vaccine stocks,” this helps narrow to names that are not only relevant fundamentally (vaccines/biotech) but also technically constructive, making trend, pullback, or breakout analysis more meaningful.

5. Sector: Healthcare; Pharmaceuticals & Medical Research

   • Purpose: Restrict the universe to industries where vaccine companies naturally reside.
   • Rationale:
     • Vaccine developers and manufacturers are almost exclusively within Healthcare, often specifically in Pharmaceuticals, Biotechnology, or Medical Research.
     • Filtering by these sectors ensures you’re not picking up unrelated industries where “biotech” might be misclassified or tangential.

6. Theme: Biotech

   • Purpose: Directly target companies involved in biotechnology, where vaccine R&D is concentrated.
   • Rationale:
     • Most pure-play vaccine developers and platform companies (e.g., mRNA, viral vectors, protein subunits) are categorized as biotech.
     • By combining the Biotech theme with the Healthcare/Pharma sectors, the screen homes in on the subset of stocks most likely to be vaccine-related or adjacent (infectious disease, immunology, etc.).

Why Results Match:

• The sector and biotech theme filters ensure you’re looking specifically at healthcare/biotech names where vaccine development activity is most likely, aligning with “vaccine stocks.”
• The market cap and volume filters focus on more established, liquid names where technical analysis tends to be more reliable and tradable.
• The RSI “moderate” and PriceAboveMA20 filters layer on a technical-quality screen, selecting stocks with reasonable momentum and non-extreme conditions—exactly the kind of setup where technical analysis (trend lines, breakouts, support/resistance) is most useful.

Taken together, these filters narrow the universe to vaccine-related biotech/healthcare stocks that are liquid, reasonably sized, and showing constructive technical behavior, which fits the goal of performing technical analysis on vaccine stocks.